Summary of WARNER CHILCOTT PLC

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

WCRX > SEC Filings for WCRX > Form 8-K on 5-Feb-2013

All Recent SEC Filings

Show all filings for WARNER CHILCOTT PLC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for WARNER CHILCOTT PLC

5-Feb-2013

Other Events, Financial Statements and Exhibits

Item 8.01. Other Events.

On February 5, 2013, Warner Chilcott plc issued a press release announcing that the United States Food and Drug Administration had approved its new 400 mg mesalamine product indicated for the treatment of ulcerative colitis, which will be marketed as DELZICOL™ (mesalamine) 400 mg delayed-release capsules.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit
Number  Description

 99.1   Press Release issued February 5, 2013

Add WCRX to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for WCRX - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.